First Time Loading...

Xencor Inc
NASDAQ:XNCR

Watchlist Manager
Xencor Inc Logo
Xencor Inc
NASDAQ:XNCR
Watchlist
Price: 21.13 USD 3.78%
Updated: May 15, 2024

Intrinsic Value

XNCR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Xencor, Inc. is biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. [ Read More ]

The intrinsic value of one XNCR stock under the Base Case scenario is 34.02 USD. Compared to the current market price of 21.13 USD, Xencor Inc is Undervalued by 38%.

Key Points:
XNCR Intrinsic Value
Base Case
34.02 USD
Undervaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Xencor Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling XNCR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Xencor Inc

Provide an overview of the primary business activities
of Xencor Inc.

What unique competitive advantages
does Xencor Inc hold over its rivals?

What risks and challenges
does Xencor Inc face in the near future?

Has there been any significant insider trading activity
in Xencor Inc recently?

Summarize the latest earnings call
of Xencor Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Xencor Inc.

Provide P/S
for Xencor Inc.

Provide P/E
for Xencor Inc.

Provide P/OCF
for Xencor Inc.

Provide P/FCFE
for Xencor Inc.

Provide P/B
for Xencor Inc.

Provide EV/S
for Xencor Inc.

Provide EV/GP
for Xencor Inc.

Provide EV/EBITDA
for Xencor Inc.

Provide EV/EBIT
for Xencor Inc.

Provide EV/OCF
for Xencor Inc.

Provide EV/FCFF
for Xencor Inc.

Provide EV/IC
for Xencor Inc.

Show me price targets
for Xencor Inc made by professional analysts.

What are the Revenue projections
for Xencor Inc?

How accurate were the past Revenue estimates
for Xencor Inc?

What are the Net Income projections
for Xencor Inc?

How accurate were the past Net Income estimates
for Xencor Inc?

What are the EPS projections
for Xencor Inc?

How accurate were the past EPS estimates
for Xencor Inc?

What are the EBIT projections
for Xencor Inc?

How accurate were the past EBIT estimates
for Xencor Inc?

Compare the revenue forecasts
for Xencor Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Xencor Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Xencor Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Xencor Inc compared to its peers.

Compare the P/E ratios
of Xencor Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Xencor Inc with its peers.

Analyze the financial leverage
of Xencor Inc compared to its main competitors.

Show all profitability ratios
for Xencor Inc.

Provide ROE
for Xencor Inc.

Provide ROA
for Xencor Inc.

Provide ROIC
for Xencor Inc.

Provide ROCE
for Xencor Inc.

Provide Gross Margin
for Xencor Inc.

Provide Operating Margin
for Xencor Inc.

Provide Net Margin
for Xencor Inc.

Provide FCF Margin
for Xencor Inc.

Show all solvency ratios
for Xencor Inc.

Provide D/E Ratio
for Xencor Inc.

Provide D/A Ratio
for Xencor Inc.

Provide Interest Coverage Ratio
for Xencor Inc.

Provide Altman Z-Score Ratio
for Xencor Inc.

Provide Quick Ratio
for Xencor Inc.

Provide Current Ratio
for Xencor Inc.

Provide Cash Ratio
for Xencor Inc.

What is the historical Revenue growth
over the last 5 years for Xencor Inc?

What is the historical Net Income growth
over the last 5 years for Xencor Inc?

What is the current Free Cash Flow
of Xencor Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Xencor Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xencor Inc

Current Assets 562.3m
Cash & Short-Term Investments 535.9m
Receivables 9.6m
Other Current Assets 16.7m
Non-Current Assets 322m
Long-Term Investments 198.5m
PP&E 103.8m
Intangibles 18.9m
Other Non-Current Assets 880k
Current Liabilities 79.4m
Accounts Payable 16m
Accrued Liabilities 15.6m
Other Current Liabilities 47.8m
Non-Current Liabilities 192.3m
Long-Term Debt 12.5m
Other Non-Current Liabilities 179.8m
Efficiency

Earnings Waterfall
Xencor Inc

Revenue
162.2m USD
Operating Expenses
-299.4m USD
Operating Income
-137.2m USD
Other Expenses
3.7m USD
Net Income
-133.4m USD

Free Cash Flow Analysis
Xencor Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

XNCR Profitability Score
Profitability Due Diligence

Xencor Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional 1-Year Revenue Growth
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
28/100
Profitability
Score

Xencor Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

XNCR Solvency Score
Solvency Due Diligence

Xencor Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
73/100
Solvency
Score

Xencor Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XNCR Price Targets Summary
Xencor Inc

Wall Street analysts forecast XNCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XNCR is 37.31 USD with a low forecast of 22.22 USD and a high forecast of 61.95 USD.

Lowest
Price Target
22.22 USD
5% Upside
Average
Price Target
37.31 USD
77% Upside
Highest
Price Target
61.95 USD
193% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

XNCR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

XNCR Price
Xencor Inc

1M 1M
+5%
6M 6M
+12%
1Y 1Y
-24%
3Y 3Y
-47%
5Y 5Y
-39%
10Y 10Y
+162%
Annual Price Range
21.13
52w Low
16.53
52w High
28.72
Price Metrics
Average Annual Return -4.28%
Standard Deviation of Annual Returns 25.51%
Max Drawdown -69%
Shares Statistics
Market Capitalization 1.3B USD
Shares Outstanding 61 647 500
Percentage of Shares Shorted 19.53%

XNCR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Xencor Inc Logo
Xencor Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1.3B USD

Dividend Yield

0%

Description

Xencor, Inc. is biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. The company is headquartered in Monrovia California, California and currently employs 254 full-time employees. The company went IPO on 2013-12-03. The firm is advancing a portfolio of clinical-stage XmAb drug candidates from its protein engineering technology platforms. The firm uses its engineering capabilities to enable its understanding of protein structure and interactions to design technologies and XmAb development candidates with properties. The company is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Tidutamab, XmAb841, XmAb306, AMG 509, XmAb819, XmAb104, XmAb564 and Novartis XmAb.

Contact

CALIFORNIA
Monrovia California
111 W Lemon Ave
+16263055900.0
http://www.xencor.com/

IPO

2013-12-03

Employees

254

Officers

Co-Founder, CEO, President & Director
Dr. Bassil I. Dahiyat Ph.D.
Executive VP of Research & Chief Scientific Officer
Dr. John R. Desjarlais Ph.D.
Senior VP, General Counsel & Corporate Secretary
Ms. Celia E. Eckert J.D.
Executive VP & Chief Development Officer
Dr. Nancy Valente M.D.
Senior VP & CFO
Mr. Bart Cornelissen
Associate Director and Head of Corporate Communications & Investor Relations
Mr. Charles Liles
Show More
Vice President of Human Resources
Ms. Jennifer Sandoz
Senior Vice President of Business Development
Dr. Jeremy Grunstein Ph.D.
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. Kirk Rosemark RAC
Senior Vice President of Program Leadership & Alliance Management
Mr. Eric P. Kowack
Show Less

See Also

Discover More
What is the Intrinsic Value of one XNCR stock?

The intrinsic value of one XNCR stock under the Base Case scenario is 34.02 USD.

Is XNCR stock undervalued or overvalued?

Compared to the current market price of 21.13 USD, Xencor Inc is Undervalued by 38%.